These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28904359)

  • 1. Structured illumination microscopy and automatized image processing as a rapid diagnostic tool for podocyte effacement.
    Siegerist F; Ribback S; Dombrowski F; Amann K; Zimmermann U; Endlich K; Endlich N
    Sci Rep; 2017 Sep; 7(1):11473. PubMed ID: 28904359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Super-resolved local recruitment of CLDN5 to filtration slits implicates a direct relationship with podocyte foot process effacement.
    Tesch F; Siegerist F; Hay E; Artelt N; Daniel C; Amann K; Zimmermann U; Kavvadas P; Grisk O; Chadjichristos C; Endlich K; Chatziantoniou C; Endlich N
    J Cell Mol Med; 2021 Aug; 25(16):7631-7641. PubMed ID: 34156149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bi-nucleation of podocytes is uniformly accompanied by foot processes widening in renal disease.
    Mühldorfer J; Pfister E; Büttner-Herold M; Klewer M; Amann K; Daniel C
    Nephrol Dial Transplant; 2018 May; 33(5):796-803. PubMed ID: 29106627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies.
    Meyer-Schwesinger C; Meyer TN; Münster S; Klug P; Saleem M; Helmchen U; Stahl RA
    J Pathol; 2009 Feb; 217(3):452-64. PubMed ID: 18985619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis.
    Deegens JK; Dijkman HB; Borm GF; Steenbergen EJ; van den Berg JG; Weening JJ; Wetzels JF
    Kidney Int; 2008 Dec; 74(12):1568-76. PubMed ID: 18813290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Analysis of Podocyte Foot Process Morphology in Three Species by 3D Super-Resolution Microscopy.
    Artelt N; Siegerist F; Ritter AM; Grisk O; Schlüter R; Endlich K; Endlich N
    Front Med (Lausanne); 2018; 5():292. PubMed ID: 30425988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of podocyte-associated molecules in acquired human kidney diseases.
    Koop K; Eikmans M; Baelde HJ; Kawachi H; De Heer E; Paul LC; Bruijn JA
    J Am Soc Nephrol; 2003 Aug; 14(8):2063-71. PubMed ID: 12874460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Microscopic Techniques for Podocyte Research.
    Siegerist F; Endlich K; Endlich N
    Front Endocrinol (Lausanne); 2018; 9():379. PubMed ID: 30050501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting podocyte-associated diseases.
    Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria.
    Lahdenkari AT; Lounatmaa K; Patrakka J; Holmberg C; Wartiovaara J; Kestilä M; Koskimies O; Jalanko H
    J Am Soc Nephrol; 2004 Oct; 15(10):2611-8. PubMed ID: 15466265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria.
    Tøndel C; Kanai T; Larsen KK; Ito S; Politei JM; Warnock DG; Svarstad E
    Nephron; 2015; 129(1):16-21. PubMed ID: 25531941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosage-dependent role of Rac1 in podocyte injury.
    Wan X; Lee MS; Zhou W
    Am J Physiol Renal Physiol; 2016 Apr; 310(8):F777-F784. PubMed ID: 26792065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinuria with and without renal glomerular podocyte effacement.
    Kalluri R
    J Am Soc Nephrol; 2006 Sep; 17(9):2383-9. PubMed ID: 16914535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?
    Müller-Deile J; Schiffer M
    Pediatr Nephrol; 2016 Mar; 31(3):393-405. PubMed ID: 25939817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of podocyte slit diaphragms is decreased in minimal change nephrotic syndrome.
    Patrakka J; Lahdenkari AT; Koskimies O; Holmberg C; Wartiovaara J; Jalanko H
    Pediatr Res; 2002 Sep; 52(3):349-55. PubMed ID: 12193666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-characterization of the Glomerulopathy in CD2AP Deficient Mice by High-Resolution Helium Ion Scanning Microscopy.
    Tsuji K; Păunescu TG; Suleiman H; Xie D; Mamuya FA; Miner JH; Lu HAJ
    Sci Rep; 2017 Aug; 7(1):8321. PubMed ID: 28814739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural changes of podocyte foot processes during the remission phase of minimal change disease of human kidney.
    Liu XJ; Zhang YM; Wang SX; Liu G
    Nephrology (Carlton); 2014 Jul; 19(7):392-7. PubMed ID: 24690133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies.
    van den Berg JG; van den Bergh Weerman MA; Assmann KJ; Weening JJ; Florquin S
    Kidney Int; 2004 Nov; 66(5):1901-6. PubMed ID: 15496161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial cell foot process effacement in podocytes in focal and segmental glomerulosclerosis: a quantitative analysis.
    Kfoury H
    Ultrastruct Pathol; 2014 Oct; 38(5):303-8. PubMed ID: 24956069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.